The primary objective of this study was to determine the correlation between elevated levels of the CA 11-19 tumor marker in blood and the presence of colorectal cancer or pre-cancer.
- Seeking Alpha: Augury Investments discusses Exact Sciences and EDP Biotech
- One Knoxville company wins, another competing in InnoSTARS China event
- Knoxville-based EDP BioTech Corporation was invited to compete in the “InnoSTARS Competition Semi-Final for Biomedicine & Medical Device Group
- American Cancer Society Updates: Colorectal Cancer Screening Guideline
- EDP Biotech goes to Path C that also opens-up some new opportunities